Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.923,35
0,20%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Concert Pharmaceuticals Inc (CNCE) Concert Pharmaceuticals Inc (CNCE) Notizie

CNCE

Concert Pharmaceuticals (CNCE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNCE
DataOraFonteTitoloSimboloCompagnia
16/03/202314:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202311:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202317:58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202317:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202315:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202315:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202315:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202313:00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202323:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/02/202315:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202314:12Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202313:32Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/02/202323:13Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202316:40Dow Jones NewsConcert Pharmaceuticals Shares Rally on Takeover by SunNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202314:47Dow Jones NewsSun Pharmaceutical to Buy Concert Pharmaceuticals For Initial $576 MillionNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202314:00Business WireSun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
10/12/202200:25TipRanksJonesTrading Keeps Their Buy Rating on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
22/11/202212:25TipRanksH.C. Wainwright Remains a Buy on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
21/11/202213:00Business WireConcert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair ResearchNASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/202213:00Business WireConcert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202212:25TipRanksConcert Pharma (CNCE) Gets a Buy from H.C. WainwrightNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202204:25TipRanksConcert Pharma (CNCE) Receives a Buy from JonesTradingNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202218:05TipRanksConcert Pharma (CNCE) Gets a Buy from JMP SecuritiesNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202213:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202213:00Business WireConcert Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
31/10/202212:00Business WireConcert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
13/09/202203:05TipRanksJonesTrading Sticks to Their Buy Rating for Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
10/09/202211:30Business WireConcert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV CongressNASDAQ:CNCEConcert Pharmaceuticals Inc
06/09/202213:00Business WireConcert Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
01/09/202213:00Business WireBridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CNCE

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network